XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.48%3.13B | 12.18%820M | 3.53%792M | -1.67%767M | -11.56%742M | -1.17%3.12B | -16.27%731M | -7.61%765M | 1.96%780M | 22.30%839M |
Net interest income | -0.33%2.43B | 7.55%627M | 5.98%620M | 1.02%597M | -13.70%586M | -3.25%2.44B | -19.03%583M | -11.76%585M | -0.34%591M | 24.82%679M |
-Net interest income | 8.77%4.29B | 2.12%1.06B | 9.31%1.1B | 9.83%1.07B | 14.57%1.05B | 45.91%3.95B | 24.55%1.04B | 42.86%1.01B | 60.69%977M | 65.77%920M |
-Interest income from loans and lease | 9.95%3.51B | 2.95%873M | 8.18%899M | 10.87%877M | 19.15%865M | 51.33%3.2B | 29.27%848M | 50.82%831M | 69.02%791M | 66.13%726M |
-Interest income from securities | 3.73%779M | -1.56%189M | 14.53%205M | 5.38%196M | -2.58%189M | 26.64%751M | 7.26%192M | 14.74%179M | 32.86%186M | 64.41%194M |
-Total interest expense | 23.46%1.86B | -4.81%435M | 13.88%484M | 23.32%476M | 94.19%468M | 715.68%1.51B | 297.39%457M | 865.91%425M | 2,473.33%386M | 2,090.91%241M |
-Interest expense for deposit | 44.87%1.54B | -6.08%371M | 10.11%403M | 77.27%390M | 358.54%376M | 1,418.57%1.06B | 939.47%395M | 1,826.32%366M | 3,042.86%220M | 1,266.67%82M |
-Interest expense for long term debt and capital securities | -27.58%323M | 3.23%64M | 37.29%81M | -48.19%86M | -42.14%92M | 287.83%446M | -19.48%62M | 136.00%59M | 1,975.00%166M | 3,080.00%159M |
Non interest income | 3.40%700M | 30.41%193M | -4.44%172M | -10.05%170M | -2.50%156M | 7.12%677M | -3.27%148M | 9.09%180M | 9.88%189M | 12.68%160M |
-Fees and commissions | 3.06%639M | 15.33%173M | 2.55%161M | -4.94%154M | 0.00%151M | 0.98%620M | -1.96%150M | 0.64%157M | 5.19%162M | 0.00%151M |
-Gain loss on sale of assets | --19M | 210.00%11M | -45.45%6M | 200.00%3M | 50.00%-1M | --0 | -11.11%-10M | 10.00%11M | -90.91%1M | 81.82%-2M |
-Dividend income | -26.32%42M | 12.50%9M | -58.33%5M | -50.00%13M | -45.45%6M | 235.29%57M | -11.11%8M | 1,300.00%12M | 271.43%26M | 450.00%11M |
Credit losses provision | 45.45%-72M | -41M | 68.29%-13M | 89.13%-5M | 71.11%-13M | -8.20%-132M | 0 | 42.25%-41M | -12.20%-46M | -236.36%-45M |
Non interest expense | 2.01%2.03B | 4.07%511M | 1.21%501M | 2.42%507M | 0.39%513M | 6.13%1.99B | 4.25%491M | 3.34%495M | 6.91%495M | 10.13%511M |
Occupancy and equipment | 0.63%161M | 10.53%42M | -4.76%40M | 0.00%40M | -2.50%39M | 5.26%160M | -5.00%38M | 10.53%42M | 11.11%40M | 5.26%40M |
Professional expense and contract services expense | 3.23%64M | 0.00%17M | -12.50%14M | 6.25%17M | 23.08%16M | 8.77%62M | 13.33%17M | 14.29%16M | 14.29%16M | -7.14%13M |
Selling and administrative expenses | 0.64%1.41B | 1.45%350M | 1.76%347M | 1.16%350M | -1.90%362M | 5.74%1.4B | 4.86%345M | 1.49%341M | 5.17%346M | 11.82%369M |
-General and administrative expense | 0.74%1.36B | 1.80%340M | 1.21%335M | 1.20%337M | -1.40%352M | 5.37%1.35B | 5.03%334M | 1.85%331M | 4.06%333M | 10.87%357M |
-Selling and marketing expense | -2.17%45M | -9.09%10M | 20.00%12M | 0.00%13M | -16.67%10M | 17.95%46M | 0.00%11M | -9.09%10M | 44.44%13M | 50.00%12M |
Other non-interest expense | 7.57%398M | 12.09%102M | 4.17%100M | 7.53%100M | 7.87%96M | 7.56%370M | 4.60%91M | 5.49%96M | 10.71%93M | 8.54%89M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 86.67%-14M | 102.22%2M | 0.00%-1M | 153.85%7M | -1,200.00%-13M | -10,400.00%-105M | -90M | -1M | -1,200.00%-13M | -1M |
Gain on sale of business | ---- | ---- | ---- | --9M | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Restructuring and mergern&acquisition | -80.00%3M | --1M | 0.00%1M | -92.31%1M | --0 | 1,400.00%15M | --0 | --1M | 1,200.00%13M | --1M |
Less:Other special charges | -87.78%11M | ---3M | ---- | --1M | --13M | --90M | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 14.22%1.01B | 80.00%270M | 21.49%277M | 15.93%262M | -28.01%203M | -23.09%886M | -58.22%150M | -17.99%228M | -13.08%226M | 10.59%282M |
Income tax | 10.68%228M | 125.00%54M | 18.87%63M | 19.61%61M | -35.90%50M | -15.92%206M | -68.00%24M | -13.11%53M | -10.53%51M | 50.00%78M |
Earnings from equity interest net of tax | ||||||||||
Net income | 15.29%784M | 71.43%216M | 22.29%214M | 14.86%201M | -25.00%153M | -25.03%680M | -55.63%126M | -19.35%175M | -13.79%175M | 0.49%204M |
Net Income continuous operations | 15.29%784M | 71.43%216M | 22.29%214M | 14.86%201M | -25.00%153M | -25.03%680M | -55.63%126M | -19.35%175M | -13.79%175M | 0.49%204M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 15.29%784M | 71.43%216M | 22.29%214M | 14.86%201M | -25.00%153M | -25.03%680M | -55.63%126M | -19.35%175M | -13.79%175M | 0.49%204M |
Preferred stock dividends | 28.13%41M | 0.00%10M | 42.86%10M | 22.22%11M | 66.67%10M | 10.34%32M | 42.86%10M | 0.00%7M | 12.50%9M | -25.00%6M |
Other preferred stock dividend | 0.00%6M | 500.00%6M | 100.00%2M | 0.00%1M | 100.00%2M | -25.00%6M | -66.67%1M | 0.00%1M | -50.00%1M | -50.00%1M |
Net income attributable to common stockholders | 14.80%737M | 73.91%200M | 20.96%202M | 14.55%189M | -28.43%141M | -26.21%642M | -58.03%115M | -20.10%167M | -14.51%165M | 2.07%197M |
Basic earnings per share | 13.79%4.95 | 71.79%1.34 | 21.24%1.37 | 15.32%1.28 | -27.82%0.96 | -25.00%4.35 | -57.61%0.78 | -19.29%1.13 | -13.95%1.11 | 4.72%1.33 |
Diluted earnings per share | 13.79%4.95 | 71.79%1.34 | 21.24%1.37 | 15.32%1.28 | -27.82%0.96 | -24.87%4.35 | -57.61%0.78 | -19.29%1.13 | -13.95%1.11 | 4.72%1.33 |
Dividend per share | 1.22%1.66 | 4.88%0.43 | 0.00%0.41 | 0.00%0.41 | 0.00%0.41 | 3.80%1.64 | 0.00%0.41 | 0.00%0.41 | 7.89%0.41 | 7.89%0.41 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |